Intrinsic Value of S&P & Nasdaq Contact Us

Landos Biopharma, Inc. LABP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — LABP

Landos Biopharma, Inc. (LABP) has a market capitalization of $71.68M and trades at $22.93. The 52-week range is 3.145-22.94.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.6, Earnings Per Share (EPS) of $-3.50.

The stock has a beta of 0.14, operates in the Healthcare sector.

Trading Data
Current Price$22.93
52-Week Range3.145-22.94
Volume50.9K
Avg Volume (30D)27.04K
Market Cap$71.68M
Beta (1Y)0.14
Company
IPO Date2021-02-04
Employees19
CEOGregory Oakes
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS5150692011
CUSIP515069102
Income (Latest Year)
EBITDA$-22.73M
Operating Income$-22.73M
Net Income$-21.94M
EPS$-3.50
EPS Diluted$-3.50
Shares Outstanding$6.28M
Balance Sheet (Latest Year)
Total Assets$38.04M
Current Assets$38.04M
Cash & ST Investments$37.55M
Total Liabilities$6.25M
Net Debt$-37.55M
Total Equity$31.79M
Valuation Ratios
P/E Ratio-6.6
P/B Ratio2.25
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message